Have a Question?
Contact us to learn more & find out how Maetrics can solve your regulatory or compliance issues.
New responsibilities for Economic Operators will shake up the medical device market, and this new free whitepaper aims to draw attention to the fact that three out of four Economic Operators are now legally and severally liable for devices sold on the market. This is an unprecedented change in regulation, with potential serious consequences […]February 12, 2020
Manufacturers of drug device combination products have until 26th May 2020 (and until 26th May 2022 for companion diagnostics) to comply with the the EU Medical Device Regulation (MDR) or risk losing European market access. Maetrics’ newest whitepaper details the adaptations and additions MDR pertaining to drug device combination products. The whitepaper looks closely […]June 13, 2019
The MDR has been on the regulatory horizon for a long time, with draft versions published in 2016 and the final version in May 2017. The MDR transition period ends on May 26th 2020 at which point any non-compliant manufacturers will be restricted from selling and distributing their products on the EU market. Any […]May 7, 2019
May 2020 – Maetrics, an international leader in life sciences quality and regulatory consulting, has appointed Dr Amie Smirthwaite as Senior Director of the Global Clinical Practice. A clinical and regulatory affairs expert, Amie has over 25 years’ postdoctoral experience in medical devices, spanning new product development, quality and regulatory systems and clinical data evaluation. […]May 18, 2020
You may have heard the EU Medical Device Regulation (EU MDR) date of application is being delayed one year, but might be wondering what it really means. For some this is welcome news and allows more time to get ready, for others it doesn’t change much. The vote to delay was approved by an overwhelming margin […]April 28, 2020
Maetrics is committed to partnering with our clients to deliver critical supplies and services during this global pandemic. Our priority remains safeguarding our employees, clients and communities, while continuing to deliver the compliance support that is needed. At the beginning of each year we develop a core message to motivate and guide our efforts. Our […]March 30, 2020
Executive Forum BREXIT will bring some uncertainty to pharma operations in Europe. New product types such as biologics and personalised medicine will increase pressure to develop innovative solutions for factory building and engineering solutions. The Executive Forum will highlight these limitations and also look at how other branches shape innovation. Our programme features top speakers […]February 13, 2019
Peter Rose and Terry Gustafson will be attending this specialist MDR workshop. The aim of the day is to lead delegates through the development of a time-critical action plan for keeping medical devices on the EU market using proven strategies and tactics. At this workshop, delegates will develop: Advanced strategies to effectively work with notified bodies. […]February 13, 2019
ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements. Also covered will be: Medical devices: conformity assessment and the CE mark. How to conform to the legal requirements for placing medical devices […]November 27, 2018